CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.650
+0.130 (5.16%)
At close: May 30, 2025, 4:00 PM
2.610
-0.040 (-1.49%)
After-hours: May 30, 2025, 7:55 PM EDT
CytomX Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$5.00
Upside
+88.68%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +88.68% | May 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $2.5 → $5 | Buy | Maintains | $2.5 → $5 | +88.68% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $5 | Hold → Strong Buy | Upgrades | $5 | +88.68% | May 15, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $3.25 → $2.5 | Buy | Maintains | $3.25 → $2.5 | -5.66% | Apr 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 27, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $2.25 → $3.5 | Hold → Buy | Upgrades | $2.25 → $3.5 | +32.08% | May 28, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $3.25 → $3.59 | Hold | Maintains | $3.25 → $3.59 | +35.47% | May 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 9, 2024 |
| Wedbush | Wedbush | Hold → Buy Upgrades $3 → $8 | Hold → Buy | Upgrades | $3 → $8 | +201.89% | May 9, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $2.5 → $8 | Hold → Strong Buy | Upgrades | $2.5 → $8 | +201.89% | May 6, 2024 |
| BMO Capital | BMO Capital | Hold Reiterates $3.25 | Hold | Reiterates | $3.25 | +22.64% | May 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.